NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NaturalAntibody

NaturalAntibody

Private
SzczecinHealthcare & Life Scienceshttps://naturalantibody.com/

Last Round

Grant

Dec 16, 2021

Total Funding Raised

$3.31M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

NaturalAntibody is a bioinformatics company that develops an AI-powered computational platform to accelerate the discovery and design of therapeutic antibodies.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Vertical SaaS

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

antibody discoveryantibody engineeringbioinformatics softwarein silico drug discoverytherapeutic antibodyantibody databasesequence analysisdevelopability predictionantibody dockingcomputational biologydrug discovery platformbiotech softwareAI drug discoverydigital biologySaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NaturalAntibody Comparables

Compare NaturalAntibody with similar companies based on industry and business-model similarity.

NaturalAntibody comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ENPICOM
82%
Cyrus Biotechnology
78%
Siemens
77%

NaturalAntibody Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 16, 2021
SeedAug 24, 2021

NaturalAntibody Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors grew 82% MoM, reaching 5.9K.

  • Mar 1, 2026

    Monthly visitors increased 54% MoM.

NaturalAntibody Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NaturalAntibody Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NaturalAntibody's valuation, stock price, and market status.

Firmographic Details

HeadquartersSzczecin
Employee Range23
Year Founded2020
Last FundingDec 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.